Jpmorgan Chase & CO Artivion, Inc. Transaction History

Jpmorgan Chase & CO

$1.14 Trillion
Q2 2024

A detailed history of Jpmorgan Chase & CO transactions in Artivion, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 19,783 shares of AORT stock, worth $529,195. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,783

Previous 52,343 62.21%

Holding current value

$529,195

Previous $1.11 Million 54.2%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$19.62 - $25.65 $638,827 - $835,164	-32,560 Reduced 62.21%	19,783 $507,000
Q1 2024 May 10, 2024	BUY	$16.7 - $21.63 $404,507 - $523,921	24,222 Added 86.13%	52,343 $1.11 Million
Q4 2023 Feb 12, 2024	SELL	$12.33 - $18.83 $24,277 - $37,076	-1,969 Reduced 6.54%	28,121 $502,000
Q3 2023 Nov 14, 2023	SELL	$14.82 - $17.52 $51,855 - $61,302	-3,499 Reduced 10.42%	30,090 $456,000
Q2 2023 Aug 11, 2023	SELL	$12.78 - $17.23 $2,811 - $3,790	-220 Reduced 0.65%	33,589 $577,000
Q1 2023 May 18, 2023	BUY	$11.74 - $14.12 $350,251 - $421,256	29,834 Added 750.54%	33,809 $442,000
Q1 2023 May 11, 2023	SELL	$11.74 - $14.12 $258,080 - $310,399	-21,983 Reduced 84.69%	3,975 $52,000
Q4 2022 Feb 13, 2023	BUY	$10.01 - $13.9 $17,747 - $24,644	1,773 Added 7.33%	25,958 $315,000
Q3 2022 Nov 14, 2022	BUY	$13.31 - $23.25 $2,116 - $3,696	159 Added 0.66%	24,185 $336,000
Q2 2022 Aug 11, 2022	BUY	$15.73 - $22.91 $94,490 - $137,620	6,007 Added 33.34%	24,026 $453,000
Q1 2022 May 11, 2022	SELL	$16.95 - $21.74 $255,470 - $327,665	-15,072 Reduced 45.55%	18,019 $386,000
Q4 2021 Feb 10, 2022	SELL	$17.19 - $22.84 $119,762 - $159,126	-6,967 Reduced 17.39%	33,091 $674,000
Q3 2021 Nov 12, 2021	BUY	$22.29 - $28.7 $892,892 - $1.15 Million	40,058 New	40,058 $893,000

Others Institutions Holding AORT

# of Institutions

163

Shares Held

35.4M

Call Options Held

21K

Put Options Held

6.8K

View Full List

About ARTIVION, INC.

Ticker AORT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 40,316,100
Market Cap $1.08B
Description
Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...

More about AORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Artivion, Inc. Transaction History